Logo

Qiagen, Evotec Form RNAi Imaging Technology Partnership

Sep 13, 2004

NEW YORK, Sept. 13 (GenomeWeb News) - Qiagen said today that it has signed a deal to combine its TOM-amidites chemistry-based RNAi products with Evotec Technologies' imaging Opera platform.

 

According to Qiagen, the companies intend to publish scientific application notes that applications that can be more easily accomplished using the combination of the technologies. The first application note, "Ultra High-Throughput Gene Silencing for Rapid, Economical Functional Genomics Studies," will be published by Qiagen in the "near future," the company said.

 

Financial terms of the arrangement were not disclosed.

 

Breaking News
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.